Substituted piperazines as CB1 antagonists

Details for Australian Patent Application No. 2005311930 (hide)

Owner Schering Corporation

Inventors Scott, Jack D.; Greenlee, William J.; Gilbert, Eric J.; Weinstein, Jay; Stamford, Andrew W.; Miller, Michael W.

Agent Griffith Hack

Pub. Number AU-B-2005311930

PCT Pub. Number WO2006/060461

Priority 60/633,106 03.12.04 US

Filing date 1 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 6 August 2009

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/060461 Priority application(s): WO2006/060461

6 August 2009 Application Accepted

  Published as AU-B-2005311930

3 December 2009 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311931-Compositions and methods of treating irritation and kit therefor

2005311929-Treating acute exacerbations of asthma using a ketolide